FDA: Weight Loss Drug Shortage Is Over — For Now

To address the GLP-1 drug shortages, manufacturer Eli Lilly spent billions ramping up production of Mounjaro and Zepbound.

August 8, 2024   TODAY'S TOP STORY FDA: Weight Loss Drug Shortage Is Over — For Now READ ON   SPECIAL FEATURE 95-Year-Old Sally Froelich Shares the Secrets of Becoming a SuperAger READ ON   What You Need to Know About DHT and Hair Loss READ ON   Everything You Need to Know About the Birth Control Implant READ ON MORE STORIES RESOURCE FOR YOU With Bezzy Psoriasis, you're never alone.   Join others who understand what you're going through, and discover a safe space for community, guidance, and support to manage Psoriasis symptoms together. LEARN MORE Bezzy and Healthline are owned by RVO Health.   HEALTHLINE VIDEO     Through An Artist's Eye Video tips and stories about breast cancer and honest conversations with people in the breast cancer community. WATCH NOW         HEALTHLINE RESOURCE Hunger Cues With Abbey Sharp   Do you ever find that no matter how much you eat, you're never full? Learn more about this from Abbey Sharp, a registered dietician. LEARN MORE What we're reading next • Medicare Coverage for Parkinson's Disease • Is There a Link Between Anemia and Leukemia? • Your Guide to Navigating Remission from Breast Cancer • Chronic Stress Recovery: Strategies and Next Steps Until then, Take care of yourself, and we'll see you again soon! View in browser Did a friend send you this email? Subscribe here. To see all newsletters, click here. Privacy   |   Unsubscribe Our website services, content, and products are for informational purposes only. Healthline does not provide medical advice, diagnosis, or treatment and should not be used as a substitute for medical advice from a healthcare professional. Healthline encourages you to make any treatment decisions with your healthcare professional. Healthline is owned by RVO Health. © 2024 RVO Health 1101 Red Ventures Drive Fort Mill, SC 29707